KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Long-Term Deferred Tax: 2024-2025

Historic Long-Term Deferred Tax for Hims & Hers Health (HIMS) over the last 1 years, with Sep 2025 value amounting to $84.9 million.

  • Hims & Hers Health's Long-Term Deferred Tax rose 56.35% to $84.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.9 million, marking a year-over-year increase of 56.35%. This contributed to the annual value of $61.6 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Hims & Hers Health's Long-Term Deferred Tax stood at $84.9 million, which was up 0.83% from $84.2 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's Long-Term Deferred Tax ranged from a high of $84.9 million in Q3 2025 and a low of $54.3 million during Q3 2024.
  • In the last 2 years, Hims & Hers Health's Long-Term Deferred Tax had a median value of $62.5 million in 2025 and averaged $69.5 million.
  • Data for Hims & Hers Health's Long-Term Deferred Tax shows a peak YoY soared of 56.35% (in 2025) over the last 5 years.
  • Over the past 2 years, Hims & Hers Health's Long-Term Deferred Tax (Quarterly) stood at $61.6 million in 2024, then spiked by 56.35% to $84.9 million in 2025.
  • Its Long-Term Deferred Tax stands at $84.9 million for Q3 2025, versus $84.2 million for Q2 2025 and $62.5 million for Q1 2025.